[Imaging methods in the diagnosis and therapy of cystic echinococcosis].
Imaging studies, ultrasonography, play a central role for the diagnosis and follow-up of cystic echinococcosis (hydatid disease) due to the non-specific clinical symptoms and still inadequate sensitivity and specificity of currently available serological tests. Due to the increasing number of people immigrating to central Europe from countries with a high incidence of cystic echinococcosis, cystic echinococcosis has become an important differential diagnosis of cystic lesions. The imaging modality to localize and stage the disease depends on the organs affected. Ultrasonography is the most important imaging technique to screen for abdominal lesions (more than 75 % of the cases). Therefore, an expert committee of the WHO Working Group on echinococcosis has recently suggested a standardized ultrasonographic classification of hepatic cystic echinococcosis. This classification proofs to be very useful for staging echinococcal cysts with respect to parasite activity. Ultrasonography is not only an excellent tool for the primary diagnosis and therapeutic decision but also for follow-up of patients treated for cystic echinococcosis. Indications for computed tomography or magnetic resonance tomography are restricted to extra abdominal disease, patients not suited for ultrasonography because of obesity or meteorism, complicated cysts and planning of surgery or interventional therapy. Apart from surgery three other treatment options are well established: (1) chemotherapy with albendazole or mebendazole, (2) percutaneous drainage and sterilization (PAIR) and (3) observation of inactive echinococcal stages ("watch and wait" approach).
Hosch
W
W
Abteilung Radiodiagnostik, Universitätsklinikum Heidelberg. waldemar_hosch@med.uni-heidelberg.de
Junghanss
T
T
Werner
J
J
Düx
M
M
D015766:Albendazole / Q000627:therapeutic use; D000923:Anticestodal Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004322:Drainage; D004443:Echinococcosis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D004444:Echinococcosis, Hepatic / Q000145:classification / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy; D004445:Echinococcosis, Pulmonary / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008463:Mebendazole / Q000627:therapeutic use; D013902:Radiography, Thoracic; D012680:Sensitivity and Specificity; D013242:Sterilization; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography; D014944:World Health Organization
D000923:Anticestodal Agents; D008463:Mebendazole; D015766:Albendazole